BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37626769)

  • 1. Deletion of
    Ophir O; Levy G; Bar E; Kimchi Feldhorn O; Rokach M; Elad Sfadia G; Barak B
    Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal deletion of Gtf2i results in developmental microglial alterations in a mouse model related to Williams syndrome.
    Bar E; Fischer I; Rokach M; Elad-Sfadia G; Shirenova S; Ophir O; Trangle SS; Okun E; Barak B
    Glia; 2024 Jun; 72(6):1117-1135. PubMed ID: 38450767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioral and myelin alterations rescuable by a remyelinating drug.
    Barak B; Zhang Z; Liu Y; Nir A; Trangle SS; Ennis M; Levandowski KM; Wang D; Quast K; Boulting GL; Li Y; Bayarsaihan D; He Z; Feng G
    Nat Neurosci; 2019 May; 22(5):700-708. PubMed ID: 31011227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams-Beuren Syndrome.
    Borralleras C; Sahun I; Pérez-Jurado LA; Campuzano V
    Mol Ther; 2015 Nov; 23(11):1691-1699. PubMed ID: 26216516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gtf2i and Gtf2ird1 mutation do not account for the full phenotypic effect of the Williams syndrome critical region in mouse models.
    Kopp N; McCullough K; Maloney SE; Dougherty JD
    Hum Mol Genet; 2019 Oct; 28(20):3443-3465. PubMed ID: 31418010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of GTF2I haploinsufficiency to Williams syndrome.
    Chailangkarn T; Noree C; Muotri AR
    Mol Cell Probes; 2018 Aug; 40():45-51. PubMed ID: 29305905
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    López-Tobón A; Shyti R; Villa CE; Cheroni C; Fuentes-Bravo P; Trattaro S; Caporale N; Troglio F; Tenderini E; Mihailovich M; Skaros A; Gibson WT; Cuomo A; Bonaldi T; Mercurio C; Varasi M; Osborne L; Testa G
    Sci Adv; 2023 Dec; 9(48):eadh2726. PubMed ID: 38019906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal Gtf2i deletion alters mitochondrial and autophagic properties.
    Nir Sade A; Levy G; Schokoroy Trangle S; Elad Sfadia G; Bar E; Ophir O; Fischer I; Rokach M; Atzmon A; Parnas H; Rosenberg T; Marco A; Elroy Stein O; Barak B
    Commun Biol; 2023 Dec; 6(1):1269. PubMed ID: 38097729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haploinsufficiency of Gtf2i, a gene deleted in Williams Syndrome, leads to increases in social interactions.
    Sakurai T; Dorr NP; Takahashi N; McInnes LA; Elder GA; Buxbaum JD
    Autism Res; 2011 Feb; 4(1):28-39. PubMed ID: 21328569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it Williams syndrome? GTF2IRD1 implicated in visual-spatial construction and GTF2I in sociability revealed by high resolution arrays.
    Dai L; Bellugi U; Chen XN; Pulst-Korenberg AM; Järvinen-Pasley A; Tirosh-Wagner T; Eis PS; Graham J; Mills D; Searcy Y; Korenberg JR
    Am J Med Genet A; 2009 Mar; 149A(3):302-14. PubMed ID: 19205026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription Factor 2I Regulates Neuronal Development via TRPC3 in 7q11.23 Disorder Models.
    Deurloo MHS; Turlova E; Chen WL; Lin YW; Tam E; Tassew NG; Wu M; Huang YC; Crawley JN; Monnier PP; Groffen AJA; Sun HS; Osborne LR; Feng ZP
    Mol Neurobiol; 2019 May; 56(5):3313-3325. PubMed ID: 30120731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Common Polymorphism in a Williams Syndrome Gene Predicts Amygdala Reactivity and Extraversion in Healthy Adults.
    Swartz JR; Waller R; Bogdan R; Knodt AR; Sabhlok A; Hyde LW; Hariri AR
    Biol Psychiatry; 2017 Feb; 81(3):203-210. PubMed ID: 26853120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of neuron-specific promoters in mouse brain transduced by intravenously administered AAV-PHP.eB.
    Radhiyanti PT; Konno A; Matsuzaki Y; Hirai H
    Neurosci Lett; 2021 Jun; 756():135956. PubMed ID: 33989730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of GTF2I promotes neuronal apoptosis and synaptic reduction in human cellular models of neurodevelopment.
    Adams JW; Vinokur A; de Souza JS; Austria C; Guerra BS; Herai RH; Wahlin KJ; Muotri AR
    Cell Rep; 2024 Mar; 43(3):113867. PubMed ID: 38416640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive-behavioral phenotypes of Williams syndrome are associated with genetic variation in the GTF2I gene, in a healthy population.
    Crespi BJ; Hurd PL
    BMC Neurosci; 2014 Nov; 15():127. PubMed ID: 25429715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons.
    Cavallo F; Troglio F; Fagà G; Fancelli D; Shyti R; Trattaro S; Zanella M; D'Agostino G; Hughes JM; Cera MR; Pasi M; Gabriele M; Lazzarin M; Mihailovich M; Kooy F; Rosa A; Mercurio C; Varasi M; Testa G
    Mol Autism; 2020 Nov; 11(1):88. PubMed ID: 33208191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duplication of GTF2I results in separation anxiety in mice and humans.
    Mervis CB; Dida J; Lam E; Crawford-Zelli NA; Young EJ; Henderson DR; Onay T; Morris CA; Woodruff-Borden J; Yeomans J; Osborne LR
    Am J Hum Genet; 2012 Jun; 90(6):1064-70. PubMed ID: 22578324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered White Matter and microRNA Expression in a Murine Model Related to Williams Syndrome Suggests That miR-34b/c Affects Brain Development via
    Grad M; Nir A; Levy G; Trangle SS; Shapira G; Shomron N; Assaf Y; Barak B
    Cells; 2022 Jan; 11(1):. PubMed ID: 35011720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region.
    Morris CA; Mervis CB; Hobart HH; Gregg RG; Bertrand J; Ensing GJ; Sommer A; Moore CA; Hopkin RJ; Spallone PA; Keating MT; Osborne L; Kimberley KW; Stock AD
    Am J Med Genet A; 2003 Nov; 123A(1):45-59. PubMed ID: 14556246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 1.3-mb 7q11.23 atypical deletion identified in a cohort of patients with williams-beuren syndrome.
    Delgado LM; Gutierrez M; Augello B; Fusco C; Micale L; Merla G; Pastene EA
    Mol Syndromol; 2013 Mar; 4(3):143-7. PubMed ID: 23653586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.